Mark Mercola
Affiliations: | Stanford University, Palo Alto, CA |
Area:
cardiologyWebsite:
http://med.stanford.edu/mercolalab.htmlGoogle:
"Mark Mercola"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kathryn L. Calame | grad student | 1981-1984 | UCLA Molecular Biology Institute | |
| Charles D. Stiles | post-doc | 1985-1991 | Harvard Medical School/Dana-Farber Cancer Institute (Neurotree) | |
| (fellow) | ||||
Children
Sign in to add trainee| Nanette Nascone-Yoder | grad student | 1992-1997 | Harvard Medical School |
| Paris Ataliotis | post-doc | Harvard Medical School | |
| Alexandre R. Colas | post-doc | Sanford Burnham Prebys Medical Discovery Institute | |
| Ann C. Foley | post-doc | Harvard Medical School (Neurotree) | |
| Rosa M. Guzzo | post-doc | Stanford School of Medicine | |
| Martha Marvin | post-doc | Harvard Medical School | |
| Kelly A. McLaughlin | post-doc | Harvard Medical School (Evolution Tree) | |
| Karen Symes | post-doc | Harvard Medical School | |
| Ke Wei | post-doc | Sanford Burnham Prebys Medical Discovery Institute | |
| Michael Levin | post-doc | 1996-2000 | Harvard Medical School |
| Kristin Bruk Artinger | post-doc | 1997-2002 | Harvard Medical School (FlyTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cheng J, Tsuda M, Okolotowicz K, et al. (2021) Small-molecule probe reveals a kinase cascade that links stress signaling to TCF/LEF and Wnt responsiveness. Cell Chemical Biology |
| McKeithan WL, Feyen DAM, Bruyneel AAN, et al. (2020) Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. Cell Stem Cell |
| Levitas A, Muhammad E, Zhang Y, et al. (2020) A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy. Plos Genetics. 16: e1009000 |
| Briganti F, Sun H, Wei W, et al. (2020) iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy. Cell Reports. 32: 108117 |
| Feyen DAM, McKeithan WL, Bruyneel AAN, et al. (2020) Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes. Cell Reports. 32: 107925 |
| Bruyneel AAN, Colas AR, Karakikes I, et al. (2019) AlleleProfileR: A versatile tool to identify and profile sequence variants in edited genomes. Plos One. 14: e0226694 |
| Halver J, Wenzel K, Sendker J, et al. (2019) Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn? Frontiers in Pharmacology. 10: 1357 |
| Hurtado C, Safarova A, Smith M, et al. (2019) Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Scientific Reports. 9: 10811 |
| Hnatiuk A, Mercola M. (2019) Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening. Cell Stem Cell. 24: 506-507 |
| Sharma A, McKeithan WL, Serrano R, et al. (2018) Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nature Protocols |